Cite

HARVARD Citation

    Kawata, A. et al. (2022). Reducing the physical, social, and emotional impact of episodic migraine: Results from erenumab STRIVE and ARISE phase III randomized trials. Headache. 62 (2), pp. 159-168. [Online]. 
  
Back to record